HOME > VC DEALS > Interius BioTherapeutics
Deal IconDeal

Interius BioTherapeutics

Interius BioTherapeutics acquired for $350M

Interius BioTherapeutics, a Philadelphia-based biopharmaceutical company, was acquired for $350 million by Kite Pharma, a Santa Monica, CA-based biopharmaceutical firm.

More on STAT+ →


ADVERTISEMENT carta_vcd_page_OCFO

Similar Health deals

The VC Industry's trusted resource

Stay informed on industry shifts, deal trends, and career opportunities in venture capital.

Jobs